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INTRODUCTION
Accelerated apoptosis of gastric epithelial cells
is one of the important events relevant to chronic,
atrophic gastritis caused by Helicobacter pylori (Hp)
infection (1, 2). Increased expression of suicide ligands
and their receptors, such as tumor necrosis factor-α
(TNF-α) (3) and the Fas receptor (4), has been sug-
gested to participate in this apoptosis. However, it
is still unclear whether distinct bacterial factors are
involved in this apoptosis.
Hp strains are grouped into two families, type I
and type II. Patients with the gastric lesions are most
often infected with type I strains that are character-
ized by the presence of the cytotoxin-associated gene
A (cagA) and the vacuolating cytotoxin gene A (vacA)
(5). Type I strains have an insertion of approximate-
ly 40 kb of foreign DNA, named the cag pathogenicity
island (PAI), and the Hp cag PAI contains 31 genes,
including cagA (6). These genes are now recognized
as transmissible DNA that encodes virulence factors
and maps in the chromosome of pathogenic organ-
isms. Among the cag PAI genes, cagE (picB), cagG,
cagH , cagI , cagL , and cagM are involved in the ac-
tivation of nuclear factor (NF)-κB and stimulation of
interleukin (IL)-8 secretion from gastric epithelial
cells (7, 8). Six of the cag PAI genes code for the
core subunits of the type IV export machinery that
can transfer CagA protein into host epithelial cells,
and translocated CagA has been shown to be tyrosine
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phosphorylated by host cells (9-12).
Compared to these virulent factors,Hp lipopolysaccharide
(LPS) is generally accepted as a low-toxic substance,
compared with those of Salmonella enterica or Escherichia
coli (E. coli) (13, 14). However, Hp LPS was been
shown to stimulate histamine release and DNA syn-
thesis in rat enterochromaffin-like cells more effec-
tively than E. coli LPS (15). We also demonstrated
that Hp LPS could enhance production of superoxide
anion in primary cultures of guinea pig gastricmucosal
cells (16, 17), suggesting that Hp LPS has an ability
to trigger innate immune responses including acti-
vation of NF-κB.
We report here that LPS from type I Hp , but not
type II strains, acts as a potent inducer of apoptosis
of cultured cells of gastric mucosa from guinea pigs.
The present findings suggest that the difference in
apoptosis-inducing action between the type I and
type II may explain, at least in part, an important
role of the cag PAI genes in the pathogenesis of Hp
infection.
MATERIALS AND METHODS
Preparation and culture of gastric mucosal cells
under LPS-free conditions
Gastric mucosal cells were isolated aseptically from
guinea pig fundic glands (17). In this study, all re-
agents used for culture were free from detectable
amounts of LPS by the Limulus amebocyte lysate
assay (Endospecy ; Seikagaku Kogyo Co., Tokyo,
Japan). The isolated cells were cultured for 2 days
in RPMI 1640 (GIBCO, Grand Island, NY), containing
50 µg/ml gentamicin, 100U/ml penicillin G, and 10%
LPS-free fetal bovine serum (FBS ; ICN Biomedicals,
Aurora, OH). This complete medium contained <
0.01 EU/ml of LPS. After culturing for 2 days, the
growing cells were composed of pit cells (about 90%),
pre-pit cells (about 5%), parietal cells (4-5%), mucous
neck cells (less than 1%), and fibroblasts (less than
1%) (17).
Isolation and culture of clinical Hp strains
The present experiments were approved by the
ethics committees of theMedical Faculty of Hokkaido
University. All procedures involving animals were
approved by the Animal Care and Use Committee
of the University of Tokushima. Clinical isolates of
Hp were established from gastric biopsy specimens
and were cultured for up to 5 days on Hp -selective
agar plates (EikenChemical Co., Tokyo, Japan) under
microaerophilic conditions (12% CO2-5% O2-83% N2).
The organisms were identified asHp by Gram-staining,
colony morphology, and positive-oxidase, -catalase,
and-urease reactions. A single colony on the agar
plate was picked up and cultured in brucella broth
(GIBCO) supplemented with 5% FBS and 10 µg/ml
vancomycin.
Determination of genotypes of clinical isolates
Bacterial genomic DNA was extracted, and PCR
was performed using the following primer sets :
vacA, 5’-ATGGAAATACAACAAACACA-3’ and 5’-
CTCCAGAACCCACACGATT-3’ or 5’-TACAAACC
TTATTGATTGATAGCC-3’ and 5’-AAGCTTGATT
GATCACTCC-3’ ; cagA, 5’-GGGGATCCATGACT
AACGAAACC-3’ and 5’-GGCTTAAGTGATGGGA
CACCCAA-3’ ; cagE , 5’-GCTAGTTATAGAGCAA
GAGGTTCAA-3’and 5’-TAGTTGTTAGTAAGGAT
CACCCCAT-3’ ; and cagG , 5’-CCCTAATATCGGT
GGTAAAAA-3’and 5’-CTATTTGCTTGGTGTCTT
ATC-3’. The sequences of these primers corresponded
to the cag PAI genes of Hp NCTC 11638. PCR was
performed under the following conditions : 35 cycles
of 1 min at 92℃, 1 min at 52℃, and 1 min at 72℃.
For Southern blot analysis, 10 µg of genomicDNA
ofHpwas digested with HaeIII, HindIII, or EcoRI (New
England Biolabs., Beverly, MA.), electrophoresed on
1% agarose gel, and then transferred onto a nylon
membrane. The cagA , cagE , cagG , and vacA probes
prepared as described above were labeled with
digoxigenin (DIG) using a PCR DIG probe synthesis
kit (Roche, Basel, Switzerland). The membrane was
treated to hydridize with one of the labeled probes
for 20 h at 42℃ in DIG Easy Hyb (Roche). After
being washed sequentially in 2x standard saline
citrate (SSC) containing 0.1% sodium dodecyl sulfate
(SDS) and 0.2x SSC-0.1% SDS, the hybridized probes
were examined using a DIG Nuleic Acid Detection
Kit (Roche).
Preparation of Hp LPS and lipid A
LPS was prepared from six clinical strains by the
hot-phenol-water method of Westphal and Jann (18)
and subsequently treated with DNase 1, RNase A,
and proteinase K, as described by Moran et al. (19).
The treated LPS was ultracentrifuged and dialyzed
against LPS-free water (Otsuka Pharmaceutical Co.,
Tokushima, Japan). LPS from E. coli K-235 strain
was purchased from Sigma Chemical Co. (St. Louis,
MO). The ketosidic linkage between core oligosaccharide
and lipid A was decomposed by boiling LPS in 0.1 M
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acetate buffer (pH 6.5) for 1 h (20). Lipid A was
pelleted by centrifugation at 3,000 x g for 30 min.
Precipitated lipid A was dissolved in LPS-free saline
(Otsuka Pharmaceutical Co.). After the purified LPS
and lipid A had been lyophilized, their dry weights
and Limulus activities were measured using a Sartorius
Supermicro (model S4 ; Sartorius, Göettingen, Ger-
many) and by the Limulus amebocyte lysate assay,
respectively.
Analyses of DNA fragmentation and nuclear mor-
phology
Cells were cultured for 48 h and treated with LPS.
Cells both floating and attached to dishes were lysed
for 30 min at 4℃ in 200 µl of 10 mM Tris-HCl buffer
(pH8.0), containing 10 mM EDTA and 0.5% (vol/vol)
Triton X-100. Fragmented DNA of these samples was
isolated and analyzed as described previously (16).
In separate experiments, cells were fixed with 2%
paraformaldehyde in PBS for 30 min at room tem-
perature and were stained with the fluorescent dye
Hoechst 33342 (Sigma Chemical Co.). Chromosomal
condensation and fragmentation were examined using
a fluorescencemicroscope, asdescribedpreviously (16).
Detection of TLR4 transcript
Total RNA was isolated from guinea pig gastric
mucosal cells by treating themwith an acid guanidinium
thiocyanate-phenol-chloroformmixture (21). Reverse
transcriptase (RT)-PCR was carried out to detect the
TLR4 transcript using the following PCR primer
sets : 5’-TCACCTGATGCTTCTTGCTG-3’ and 5’-
AGTCGTCTCCAGAAGATGTG-3’. The resultant PCR
products were separated on an agarose gel, purified
and ligated into a pCR42-TOPO vector (Invitrogen,
Carlsbad, CA.), and transformed into JM109 cells.
Transformed plasmids containing the appropriate
insert DNA were selected and sequenced with a
DNA sequencer (model ABI 377 ; PE Biosystems
Japan, Tokyo, Japan).
For measurement of the TLR4mRNA level, total
RNA (8 µg per lane) was subjected to electrophoresis
in 1% agarose gel and transferred to a nylon filter
membrane. After prehybridization, the membrane
was hybridized for 4 h at 60℃ in a Rapid hyb buffer
(Amersham Pharmacia) containing the amplified TLR4
cDNA or a cDNA probe for human glyceraldehyde-
3-phosphate dehydrogenase (GAPDH, ATCC57494 ;
American Type Culture Collection, Rockville, MD).
These probes were prelabeled with [α-32P] deoxy-CTP
using a random primer kit (Amersham Pharmacia).
The membrane was washed twice with 2x SSC con-
taining 0.5% SDS for 10 minutes at 65℃ and then
three times with 0.2x SSC containing 1% SDS. Bound
probes were autoradiographed by exposure of Kodak
X-Omat films for an appropriate time at-80℃.
Detection of TLR4 protein
An anti-TLR4antibody was raised by subcutaneous
immunization of a rabbit with a synthetic peptide
of the amino acid residues 183 to 199 of human TLR4
(22). The keyhole limpet hemocyanin-conjugated
peptide was injected into the rabbit with Freund’s
complete adjuvant. Serum was collected and further
purified by affinity chromatography with the synthetic
peptide-conjugated agarose. A membrane fraction from
guinea pig gastric mucosal cells was prepared as de-
scribed previously (17). Each sample of 20µg protein per
lane was separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) using a 7.5% polyacrylamide
gel and transferred to a polyvinylidene difluoride filter
membrane. After blocking nonspecific binding sites
with 4% purified milk casein, the membrane was in-
cubated for 1 h at room temperature with the anti-
TLR4 antibody. Bound antibodies were detected using
an enhanced chemiluminescence system (Amersham
Pharmacia, Piscataway, NJ). They were then removed
by rinsing themembranes for 15min at 50℃ in 60mM
of Tris-HCl buffer, containing 0.1mM2-mercaptoethanol
and 2% SDS. After washing with PBS, the membrane
was again subjected to immunoblotting with an anti-
body against actin (Oncogene Res., Cambridge,MA).
Analysis of TLR4 signaling
For detection of transforming growth factor-β-activated
kinase 1 (TAK1) and TAK1-binding protein 1 (TAB1),
cellular proteins were prepared in the presence of
inhibitors of both proteases and phosphatases as de-
scribed previously (23). Phosphorylation of the proteins
was also confirmed by treatment with 5 U of bacte-
rial alkaline phosphatase as previously described (23).
Each sample (20 µg protein) was separated by SDS-PAGE
in 7.5% polyacrylamide gel and transferred to a
polyvinylidene difluoride filter membrane. After block-
ing with 4% purified milk casein, the membrane was
incubated for 1 h at room temperature with a 1 : 500
dilution of polyclonal antibody against 554 to 579
amino acid residues of mouse TAK1 or 480 to 500
residues of humanTAB1 (fromDr.Matsumoto, Nagoya
University, Nagoya, Japan). Bound antibodies were
detected by the enhanced chemiluminescence sys-
tem, and then actin was detected, as described above.
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RESULTS
Effects of Hp LPS from clinical isolates on apoptosis
of gasric mucosal cells
According to the results of PCR and Southern
blot analyses, Hps 1, 2, and 3 were vacA (+) and cag
PAI (+) strains (type I).Hps 5 and 6 were determined
to be vacA (+) and cag PAI (-) strains (type II). Hp 4
was identified as a mutant with partial deletion of
cag PAI (Table 1). As listed in Table 1, the specific
Limulus activities of LPSs from cag PAI-negative strains
(Hps 5 and 6) were 4,300-to 420,000-folds lower than
those from the type I Hps , while Hp 4, a partial de-
letion mutant of cag PAI, had a similar Limulus ac-
tivity to those of type I Hp strains (Table 1).
LPS was extracted from these clinical isolates by
the hot-phenol-water method. Treatment of gastric
mucosal cells with 42 EU/ml of Hp 1 LPS caused
DNA ladder formation within 5 h (data not shown).
When cells were incubated with different concen-
trations of Hp 1 LPS for 8 h, this LPS at a concen-
tration of 42 EU/ml (385 ng/ml) or higher induced
DNA fragmentation (Fig. 1A). Based on these findings,
gastric mucosal cells were treated for 8 h with 42
EU/ ml of LPS from one of the clinical isolates. All
of the type I Hps induced apoptotic DNA ladder
formation (Fig. 1B) and increased the numbers of
apoptotic cells with condensed and fragmented nu-
clei (Fig. 1C), while Hps 4-6 failed to stimulate these
cellular responses.
Determination of active components of Hp LPS
The LPS extracted by the hot-phenol-water method
might have contaminants, such asDNA, RNA, anddena-
tured protein. Hp 1 LPS extracted by the hot-phenol-water
Table 1. Specific Limulus activities of LPS and lipid A of clinical isolatesa








vacA (+), cagA (+), cagE (+), cagG (+)
vacA (+), cagA (+), cagE (+), cagG (+)
vacA (+), cagA (+), cagE (+), cagG (+)
vacA (+), cagA (+), cagE (-), cagG (-)
vacA (+), cagA (-), cagE (-), cagG (-)








aHp genotypes were determined by PCR and Southern blot analyses, as described in MATERIALS AND
METHODS. LPS was purified from these Hps (1 through 6), as described in MATERIALS AND
METHODS. The dry weight and Limulus activity were measured.
Fig. 1. Effects of Hp LPS from clinical isolates on apoptosis of gastric mucosal cells. After cultured cells were washed with saline,
they were treated for 8 h with different concentrations of Hp 1 LPS (A) or 42 EU/ml of LPS from each clinical strain (B) in RPMI
1640 containing 0.1% FBS. These cells were harvested and analyzed for DNA ladder formation, as described in MATERIALS AND
METHODS. Results were similar in three separate experiments. The cells were stained with Hoechst 33342 (C) as described in
MATERIALS AND METHODS. Numbers of cells having condensed and fragmented nuclei were counted, and the percentages of
apoptotic cells are shown. Values are the means±SD (n=8). #Significantly increased vs. vehicle-treated cells (P<0.05 by ANOVA and
Scheffé’s test).
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methodwas treatedwithDNase1,RNaseA, or proteinase
K, but none of these enzymes removed the activity
of Hp 1 LPS (Fig. 2B, lanes 2-4). Polymyxin B in-
hibited the Hp LPS-induced ladder formation (Fig.
2B, lanes 5-8), and lipid A was confirmed to be a
bioactive component of Hp LPS (Fig. 2 A).
Effects of E. coli LPS and TNF-α on apoptosis of
gastric mucosal cells
We also tested whether the activity was specific
for Hp LPS. For this purpose, we examined the ef-
fect of E. coli LPS from a commercial source. As
shown in Fig. 3A, E. coli LPS (K-235 strain) similar-
ly induced apoptotic DNA fragmentation as observed
in Hp1. Next we examined the possibility that LPS
could stimulate gastric epithelial cells or that a con-
taminating cell population induced TNF-α. It was
previously reported that TNF-α subsequently induced
apoptosis. Recombinant mouse or human TNF-α up
to 50 ng/ml (Fig. 3B, lanes 2 or 3, respectively) did
not stimulate apoptosis. Thus, we confirmed that LPS
directly stimulated gastric mucosal cell apoptosis.
Expression of TLR4 in gastric mucosal cells
Among the TLR family members, TLR4 is now
identified as the specific receptor for LPS in vivo and
in vitro (24). Guinea pig gastric mucosal cells ex-
pressed low levels of the TLR4 transcript and de-
tectable amounts of its protein (Fig. 4A). In response
to Hp 1 LPS, gastric mucosal cells significantly in-
creased the level of TLR4 protein (Fig. 4B) in as-
sociation with an increase in the TLR4 mRNA level
(Fig. 4A).
Stimulation of TLR4 signaling by Hp LPS
We also examined whether Hp LPS actually stimu-
Fig. 2. Determination of active component of Hp LPS. Lipid A was
isolated as described in MATERIALS AND METHODS. Cultured
guinea pig gastric mucosal cells were incubated for 8 h with different
concentrations of Hp 1 lipid A (A). Hp 1 LPS (42 x 103 EU/ml) ex-
tracted by the hot-phenol-water method was treated with 0.1 mg/ml
DNase 1, 0.1 mg/ml RNase A, or 0.1 mg/ml proteinase K for 12 h,
4 h, or 4 h, respectively. Treated LPSs were boiled for 1 h to inacti-
vate the enzymes. The gastric mucosal cells were incubated for 8
h at 37℃ with saline (B, lane 1) or one of these LPSs (42 EU/ml)
(B, lanes 2-4). After Hp 1 LPS (42 EU/ml) was incubated for 1 h at
37℃ with different concentrations of polymyxin B, the gastric mucosal
cells were treated for 8 h with 42 EU/ml of Hp 1LPS (B, lanes 5-8).
The treated cells were harvested and analyzed for DNA ladder for-
mation as described in the legend to Fig. 1. Results were similar in
three separate experiments.
Fig. 3. Effect of E. coli LPS or TNF-α on DNA ladder formation. Cultured
guinea pig gastric mucosal cells were treated with different concentrations of
E. coli LPS (A), 42 EU/ml Hp 1 LPS (B, lane 1), or 50 ng/ml of recombinant
mouse (B, lane 2) human (B, lane 3) TNF-α at 37℃ for 8 h in RPMI 1640
containing 0.1% FBS. DNA fragmentation was analyzed as described in the
legend to Fig. 1. Results were similar in three separate experiments.
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lated TLR4 signaling. TAK1 is a mitogen-activated pro-
tein kinase kinase kinase that activates c-Jun N-terminal
kinase-and NF-κB-cascades (25, 26). TAK1 is now
recognized as one of the common signal transmis-
sion molecules for TLR4 and IL-1receptor signaling
pathways (26, 27). TAB1 functions as an activator
for the TAK1 (28). Treatment with Hp LPS rapidly
phosphorylated TAK1 (Fig. 5A) and TAB1 (Fig. 5B).
It should be noted that Hp 1 and E. coli LPSs acti-
vated these proteins, while Type II strains (Hps 5
and 6) did not phosphorylate them, suggesting that
the Hp cag PAI genes are necessary for the syn-
thesis of LPS that stimulates TLR4 signaling.
DISCUSSION
In this study, we showed that guinea pig gastric
Fig. 5. Phosphorylation of TAK1 and TAB1 by LPS. Cul-
tured cells were treated with 42 EU/ml of Hp 1 LPS for
the times indicated (upper panels in A and B) or with 42
EU/ml of LPS from three Hp clinical strains (Hps 1, 5,
and 6) and 34 EU/ml of E. coli for 60 min (lower panels
in A and B). Whole-cell proteins were prepared from
these cells as described inMATERIALS ANDMETHODS.
Protein extracts were also prepared from the cells after
treatment with 42 EU/ml of Hp 1 LPS for 2 h and were
treated with bacterial alkaline phosphatase (BAP) (lane
7), as described in MATERIALS AND METHODS.
Immunoblot analysis was performed with an antibody
against TAK1 or TAB1, as described inMATERIALS AND
METHODS. p-TAK1, phosphorylated TAK1 ; p-TAB1,
phosphorylated TAB1. Similar results were obtained
in three separate experiments.
Fig. 4. Detections of TLR4 transcript and protein in gastric mucosal cells. Total RNA was isolated from cultured guinea pig gastric
mucosal cells as described in MATERIALS AND METHODS. After cells had been treated with 42 EU/ml of Hp 1 LPS for the indi-
cated times, total RNA (8 µg per lane) was separated in a 1% agarose gel. Northern hybridization with the cDNA probe for TLR4 or
GAPDH was performed as described in MATERIALS AND METHODS. The levels of TLR 4 and GAPDH were quantified by laser
densitometry, and the ratios of TLR4/GAPDH are expressed as means±SD (n=4) (A). Membrane proteins were prepared from the
gastric mucosal cells as described in MATERIALS AND METHODS. Immunoblot analysis was performed with an antibody against
TLR4. Bound antibodies were then removed by rinsing the membranes for 15 min at 50℃ in 60 mM Tris-HCl buffer, containing 0.1
mM 2-mercaptoethanol and 2% SDS. The membrane was again subjected to immunoblotting with an antibody against actin. The
levels of TLR 4 and membrane-associated actin were quantified by laser densitometry, and the ratios of TLR4/actin are expressed as
the means±SD (n=4) (B). #Significantly increased vs untreated control cells (P<0.05 by ANOVA and Scheffé’s test).
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mucosal cells expressed TLR4 and were sensitive
to LPS of type I, but not to that of type II strains.
The complete genome sequencing of Hp should pro-
vide a genetic basis for more fully understanding the
biological processes. The proteins encoded within
the Hp cag PAI genes contain the motifs found in
bacterial proteins, including translocases, sensors,
permeases, flagellum assembling proteins, and com-
ponents of the type IV secretion machinery (10).
Complete or partial deletion of or insertion of a new
gene into cag PAI, or rearrangements of the genes
within cag PAI are proposed as the basis for modi-
fied or reduced virulence (6-8).
Compared with these virulence factors, less at-
tention has been paid to Hp LPS, since 1,000 to
10,000-folds higher concentrations of Hp LPS are
required for activation of host spleen cells ormacrophages
than those of LPSs from other Gram-negative bac-
teria (13, 14). In addition to the lower immunologi-
cal activities, Hp LPS contains Lewis blood antigens,
and the molecular mimicry has been proposed to
camouflage and allow colonization to persist chroni-
cally. Hp frequently changes its LPS molecule de-
pending upon culture conditions (29) and the num-
ber of passages (19). The diversity of theHp genomes,
especially encoding the outer membrane proteins
or enzymes for LPS synthesis, is known (30). How-
ever, these findings are limited to the biosynthesis
of Lewis antigens in the O-polysaccharide regions,
such as α3-fucosyltransferase gene (31). We dem-
onstrated that lipid A, but not polysaccharides, a
bioactive cell wall component ofHp, induced apoptosis,
although the molecular basis for biosynthesis of Hp
lipid A is not fully understood.
According to the information on synthetic E. coli-like
lipid A, phosphate-patterns, the numbers of acyl chains,
and fatty acid compositions are important for the
full expression of a range of biological activities (29).
For example, the lipid A composed of bisphosphates
and hexaacyl chains is more toxic than that composed
of monophosphate and tetraacyl chains (32).Hp syn-
thesizes two types of lipid A molecules ; hexaacyl-
and tetraacyl-lipid A (19, 29). Hexaacyl-lipid A has
two phosphates or phosphorylethanolamines on the
lipid A disaccharide backbone, while tetraacyl-lipid
A contains only one phosphate. The potency of Hp
tetraacyl-lipid A has about 4-fold lower toxicity on
human monocytes than that of the hexaacyl-form
(33). At present, there is no evidence that the cag
PAI genes directly participate in the synthesis of
bioactive lipid A molecule, and the genomic basis
for the linkage between the cag-PAI genes and lipid
A biosynthesis remains to be elucidated. However,
it is possible that as observed in the known virulence
genes, the cag PAI genes indirectly support the
biosynthesis of endotoxin, LPS.
TLRs are now characterized as a family of mam-
malian homologs of Drosophila Toll. Among the TLR
family, TLR4 confers responsiveness to LPS from
Gram-negative bacteria, while TLR2 responds to the
cell wall component fromGram-positive bacteria, such
as a lipoprotein (34). The difference between type I
and type II LPSs in the proapoptotic action coin-
cided with the TLR4-stimulating action. Activation
of TLR4 signaling also results in the activation of
NF-κB, a crucial transcription activator of many in-
flammatory response genes, which was previously
reported (16, 17). Accelerated apoptosis has been ob-
served in gastric mucosal lesions caused by Hp in-
fection, particularly in chronic, atrophic gastritis, while
the molecular basis for this apoptosis is not known.
At present, it is unclear whether TLR4-mediated
signalings stimulated by type I Hp LPS actually par-
ticipate in the development of gastric mucosal le-
sions. However, the present findings suggest that
the diversity of the proapoptotic action of Hp LPS
is one of the important determinants of virulence of
Gram-negative bacteria.
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